News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
213 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37186)
2018 (39119)
2019 (51333)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (31085)
Month
January (2721)
February (3480)
March (4381)
April (4039)
May (4871)
June (4841)
July (3188)
August (2609)
September (3140)
October (3520)
November (2936)
December (2392)
Day
1 (263)
2 (251)
3 (232)
4 (256)
5 (197)
8 (213)
9 (243)
10 (243)
11 (215)
12 (180)
15 (192)
16 (235)
17 (225)
18 (213)
19 (189)
20 (1)
22 (201)
23 (210)
24 (228)
25 (208)
26 (195)
27 (3)
29 (199)
30 (249)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
20
22
23
24
25
26
27
29
30
Drug Development
Alnylam Pharmaceuticals to Webcast Conference Call to Discuss Preliminary Data from Phase II Study of ALN-RSV01
June 8, 2009
·
1 min read
FDA
Orthovita, Inc. Receives FDA Clearance for CORTOSS(TM) Bone Augmentation Material in Treatment of Vertebral Compression Fractures
June 8, 2009
·
9 min read
Drug Development
Amylin Pharmaceuticals, Inc. Interim Study Results Presented at ADA 2009: Exenatide Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs
June 8, 2009
·
9 min read
Drug Development
Sangamo BioSciences, Inc. Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
June 8, 2009
·
10 min read
Drug Development
Celgene International Sárl Release: Presentations at the 14th Congress of the European Hematology Association Demonstrate VIDAZA(R) Benefits Patients with Myelodysplastic Syndromes
June 8, 2009
·
1 min read
Sanofi-Aventis (France): New Pooled Analysis Found Lantus(R) Reduced A1C and FBG Levels in Adults Over 65 with Type 2 Diabetes Compared to Those Treated with NPH
June 8, 2009
·
4 min read
Drug Development
Micromet Presents Update on Blinatumomab’s Response Rate and Duration in a Phase 1 Study in Non-Hodgkin’s Lymphoma Patients
June 8, 2009
·
7 min read
Pharm Country
MDS Pharma Services Expands Drug Discovery Capability in Asia
June 8, 2009
·
3 min read
Drug Development
Trius Therapeutics Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections
June 8, 2009
·
4 min read
Drug Development
Merck & Co., Inc. Initial Therapy with JANUMET(TM) (sitagliptin/metformin) Provided Significantly Greater Blood Sugar Lowering Compared to Metformin Alone in Patients with Type 2 Diabetes
June 8, 2009
·
1 min read
Previous
8 of 22
Next